These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19491826)

  • 1. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy.
    Trehan I; Shulman RJ; Ou CN; Maleta K; Manary MJ
    Am J Gastroenterol; 2009 Sep; 104(9):2326-33. PubMed ID: 19491826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Lactobacillus GG on intestinal integrity in Malawian children at risk of tropical enteropathy.
    Galpin L; Manary MJ; Fleming K; Ou CN; Ashorn P; Shulman RJ
    Am J Clin Nutr; 2005 Nov; 82(5):1040-5. PubMed ID: 16280436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain.
    Collins BS; Lin HC
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):382-6. PubMed ID: 21240023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbed zinc homeostasis in rural 3-5-y-old Malawian children is associated with abnormalities in intestinal permeability attributed to tropical enteropathy.
    Manary MJ; Abrams SA; Griffin IJ; Quimper MM; Shulman RJ; Hamzo MG; Chen Z; Maleta K; Manary MJ
    Pediatr Res; 2010 Jun; 67(6):671-5. PubMed ID: 20496476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple micronutrient supplementation transiently ameliorates environmental enteropathy in Malawian children aged 12-35 months in a randomized controlled clinical trial.
    Smith HE; Ryan KN; Stephenson KB; Westcott C; Thakwalakwa C; Maleta K; Cheng JY; Brenna JT; Shulman RJ; Trehan I; Manary MJ
    J Nutr; 2014 Dec; 144(12):2059-65. PubMed ID: 25411039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc or albendazole attenuates the progression of environmental enteropathy: a randomized controlled trial.
    Ryan KN; Stephenson KB; Trehan I; Shulman RJ; Thakwalakwa C; Murray E; Maleta K; Manary MJ
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1507-13.e1. PubMed ID: 24462483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of small-intestine permeability in healthy Nigerian children is altered by urinary volume and voiding status.
    Afolami I; Samuel FO; Mwangi M; Oderinde M; Diepeveen-de Bruin M; Melse-Boonstra A
    PLoS One; 2021; 16(9):e0253436. PubMed ID: 34543276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence.
    Sharara AI; Aoun E; Abdul-Baki H; Mounzer R; Sidani S; Elhajj I
    Am J Gastroenterol; 2006 Feb; 101(2):326-33. PubMed ID: 16454838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
    Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.
    Di Stefano M; Malservisi S; Veneto G; Ferrieri A; Corazza GR
    Aliment Pharmacol Ther; 2000 May; 14(5):551-6. PubMed ID: 10792117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Combined Intervention of Zinc, Multiple Micronutrients, and Albendazole Does Not Ameliorate Environmental Enteric Dysfunction or Stunting in Rural Malawian Children in a Double-Blind Randomized Controlled Trial.
    Wang AZ; Shulman RJ; Crocker AH; Thakwalakwa C; Maleta KM; Devaraj S; Manary MJ; Trehan I
    J Nutr; 2017 Jan; 147(1):97-103. PubMed ID: 27807040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
    DuPont HL; Jiang ZD; Okhuysen PC; Ericsson CD; de la Cabada FJ; Ke S; DuPont MW; Martinez-Sandoval F
    Ann Intern Med; 2005 May; 142(10):805-12. PubMed ID: 15897530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation.
    Wessells KR; Hess SY; Rouamba N; Ouédraogo ZP; Kellogg M; Goto R; Duggan C; Ouédraogo JB; Brown KH
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):348-55. PubMed ID: 23689263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease.
    Chang MS; Minaya MT; Cheng J; Connor BA; Lewis SK; Green PH
    Dig Dis Sci; 2011 Oct; 56(10):2939-46. PubMed ID: 21647654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EB 2017 Article: Interpretation of the lactulose:mannitol test in rural Malawian children at risk for perturbations in intestinal permeability.
    Ordiz MI; Davitt C; Stephenson K; Agapova S; Divala O; Shaikh N; Manary MJ
    Exp Biol Med (Maywood); 2018 May; 243(8):677-683. PubMed ID: 29597877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undernutrition, Vitamin A and Iron Deficiency Are Associated with Impaired Intestinal Mucosal Permeability in Young Bangladeshi Children Assessed by Lactulose/Mannitol Test.
    Hossain MI; Haque R; Mondal D; Mahfuz M; Ahmed AS; Islam MM; Guerrant RL; Petri WA; Ahmed T
    PLoS One; 2016; 11(12):e0164447. PubMed ID: 27906964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifaximin treatment in hepatic encephalopathy.
    Bass NM; Mullen KD; Sanyal A; Poordad F; Neff G; Leevy CB; Sigal S; Sheikh MY; Beavers K; Frederick T; Teperman L; Hillebrand D; Huang S; Merchant K; Shaw A; Bortey E; Forbes WP
    N Engl J Med; 2010 Mar; 362(12):1071-81. PubMed ID: 20335583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.